Saba Capital Amends MSF Stake: Activist Investor Updates Ownership

Schedule 13d/A - Saba Capital Management, L.P. (0001510281) (Filed By) Filing Summary
FieldDetail
CompanySchedule 13d/A - Saba Capital Management, L.P. (0001510281) (Filed By)
Filed DateMar 24, 2026
Risk Levelmedium
Pages1
Reading Time1 min
Sentimentmixed

Complexity: simple

Sentiment: mixed

Topics: activist-investing, beneficial-ownership, amendment, institutional-investor

Related Tickers: MSF

TL;DR

**Saba Capital just updated its stake in Morgan Stanley India Investment Fund, signaling potential activist moves.**

AI Summary

Saba Capital Management, L.P. filed a SCHEDULE 13D/A on March 24, 2026, indicating an amendment to their beneficial ownership in Morgan Stanley India Investment Fund, Inc. (MSF). This filing updates previous disclosures about Saba Capital's stake, which is significant because 13D filings are typically made by activist investors who own more than 5% of a company and often seek to influence management or strategy. For investors, this signals that a major institutional investor is actively managing its position in MSF, potentially indicating future strategic moves or a change in their investment thesis.

Why It Matters

This filing matters because Saba Capital Management is an activist investor, and changes in their reported ownership can signal their intent to influence Morgan Stanley India Investment Fund, Inc.'s operations or governance.

Risk Assessment

Risk Level: medium — The risk level is medium because activist investor involvement can lead to volatility, but also potential positive changes for the company.

Analyst Insight

A smart investor would monitor future filings from Saba Capital Management, L.P. regarding Morgan Stanley India Investment Fund, Inc. to understand their evolving strategy and potential impact on the fund's performance or governance.

Key Players & Entities

  • Saba Capital Management, L.P. (company) — the entity filing the SCHEDULE 13D/A
  • Morgan Stanley India Investment Fund, Inc. (company) — the subject company of the SCHEDULE 13D/A
  • 0001510281 (person) — CIK of Saba Capital Management, L.P.
  • 0000916618 (person) — CIK of Morgan Stanley India Investment Fund, Inc.
  • March 24, 2026 (date) — filing date of the SCHEDULE 13D/A

Forward-Looking Statements

  • Saba Capital Management, L.P. will continue to actively manage its position in Morgan Stanley India Investment Fund, Inc. (Saba Capital Management, L.P.) — high confidence, target: 2027-03-24
  • Morgan Stanley India Investment Fund, Inc. may experience increased scrutiny or pressure from Saba Capital Management, L.P. regarding its operational or financial strategies. (Morgan Stanley India Investment Fund, Inc.) — medium confidence, target: 2027-03-24

FAQ

What type of filing is this document?

This document is a SCHEDULE 13D/A, which is an amendment to a General Statement of Acquisition of Beneficial Ownership.

Who filed this SCHEDULE 13D/A?

Saba Capital Management, L.P. (CIK: 0001510281) filed this SCHEDULE 13D/A.

What company is the subject of this filing?

The subject company of this filing is MORGAN STANLEY INDIA INVESTMENT FUND, INC. (CIK: 0000916618).

When was this SCHEDULE 13D/A filed and accepted?

This SCHEDULE 13D/A was filed and accepted on March 24, 2026.

What is the CIK for Saba Capital Management, L.P.?

The CIK for Saba Capital Management, L.P. is 0001510281.

Filing Stats: 108 words · 1 min read · ~1 pages · Grade level 3.9 · Accepted 2026-03-24 17:49:11

Filing Documents

From the Filing

EX-99.6 2 exhibit6.htm EXHIBIT 6 Saba Capital Management, L.P.: Exhibit 6 - Filed by newsfilecorp.com EXHIBIT 6 Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital from the filing of the Schedule 13D/A on 2/26/26 to 3/23/26, the date of the event which required filing of this Schedule 13D/A. All trades were effected in the open market. Trade Date Buy/Sell Shares Price 2/26/2026 Sell 8,830 24.05 2/27/2026 Sell 4,917 23.72 3/4/2026 Sell 17,099 23.07 3/9/2026 Sell 21,481 22.69 3/11/2026 Sell 2,695 22.51 3/13/2026 Sell 11,611 21.61 3/19/2026 Sell 24,270 21.20 3/23/2026 Sell 26,436 21.12

View Full Filing

View this filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.